Oct 6, 2023, 14:27 by Molly McGrath

On October 5th, the Ohio Society of Addiction Medicine (OHSAM) submitted comments in response to the Ohio Medical Board's proposed Physician Rules Relating to Buprenorphine Treatment.

Oct 5, 2023, 12:56 by Bob Davis

The first volume of the fourth and newest edition of the book of standards at the center of America’s addiction treatment ecosystem is now available digitally—updated and enhanced to reflect current research and clinical best practices that facilitate better, patient-centered care and improve outcomes for the millions of people diagnosed with substance use disorders each year. Preorders of the print version are also now open.

Oct 4, 2023, 12:49 by Bob Davis

With a broad coalition, ASAM signed a letter supporting the Helping Tobacco Users Quit Act (H.R. 4775), sent on September 28th to its sponsors, U.S. House Representatives Blunt Rochester and Fitzpatrick. The legislation would ensure Medicaid and Children’s Health Insurance Program (CHIP) enrollees have access to all evidence-based tobacco cessation treatments, including seven Food and Drug Administration-approved medications.

Oct 3, 2023, 12:00 by ASAM Weekly Editors

Tucked within social determinants of health are commercial determinants which have a particular interest in “addictiveness.” This is clearly evident in the lead article demonstrating how tobacco companies shifted the US food industry towards hyperpalatability beginning in the 1980s (Addiction).

Oct 2, 2023, 11:08 by Bob Davis

Sep 27, 2023, 13:01 by Molly McGrath

Sep 27, 2023, 12:53 by ASAM Weekly Editors

Both the RAND Corporation and SAMHSA recently released reports providing broad perspectives on addiction in America. At over 600 pages, “America’s Opioid Ecosystem” (RAND) is a comprehensive review of the dynamic systems and issues underlying not only America’s opioid crisis but the entire addiction ecosystem.

Sep 20, 2023, 11:53 by ASAM Weekly Editors

This week we showcase publications from leading journals across the scientific fields. In a way, this mirrors the diversity of specialists in clinical settings and beyond who collaborate to treat addiction.

Sep 14, 2023, 18:25 by Molly McGrath

ASAM joined several other organizations in a letter to the leadership of the House Committee on Oversight and Accountability opposing the U.S. Shipping Equity Act (H.R. 3721) that would allow the U.S. Post Office (USPS) to ship beverage alcohol.

Sep 13, 2023, 11:20 by ASAM Weekly Editors

Prevalence of Cannabis Use Disorder and Reasons for Use Among Adults.

Sep 9, 2023, 06:05 by Molly McGrath

Sep 7, 2023, 19:54 by Molly McGrath

Sep 6, 2023, 13:52 by ASAM Weekly Editors

Examining sociodemographic correlates of opioid use, misuse, and use disorders in the All of Us Research Program

Aug 30, 2023, 11:52 by ASAM Weekly Editors

Marijuana and hallucinogen use, binge drinking reached historic highs among adults 35 to 50

Aug 23, 2023, 09:06 by ASAM Weekly Editors

Perceptions of Safety of Daily Cannabis vs Tobacco Smoking and Secondhand Smoke Exposure, 2017-2021

Aug 21, 2023, 12:18 by Molly McGrath

On August 16th, the Louisiana Society of Addiction Medicine (LASAM) sent a letter to the Louisiana State Board of Medical Examiners (LSBME) regarding the implementation of the state’s newly enacted telehealth law.

Aug 16, 2023, 10:26 by ASAM Weekly Editors

The Future of Addiction Treatment Lies in Narrowing the Treatment Gap

Aug 14, 2023, 10:27 by Dr. Brian Hurley, MD, MBA, FAPA, DFASAM

In the time of the worst overdose crisis in American history, those of us who work in the field of addiction medicine have the responsibility of bringing treatment to where patients with addiction are. The addiction treatment gap refers to the approximately 94% of people with one or more DSM-5 defined substance use disorders (SUDs) who did not receive any addiction treatment (according to the SAMHSA’s National Survey on Drug Use and Health (NSDUH) conducted in 2021).

Aug 9, 2023, 09:20 by ASAM Weekly Editors

ASAM Clinical Considerations: Buprenorphine Treatment of Opioid Use Disorder

Aug 3, 2023, 15:07 by Molly McGrath

On July 28, 2023, ASAM responded to a request for information (RFI) from the US Department of Health and Human Services (HHS) regarding a proposed framework to support and accelerate treatment and remission from nicotine/tobacco use disorder (TUD).